发明名称 Cytokine antagonists for neurological and neuropsychiatric disorders
摘要 Methods for treating neurological or neuropsychiatric diseases or disorders in humans by administering to the human a therapeutically effective dose of specific biologics are presented. The biologics of consideration include antagonists of tumor necrosis factor or of interleukin-1. The administration of these biologics is performed by specific methods, most, but not all of which fall into the category of anatomically localized administration designed for perispinal use. Anatomically localized administration involving perispinal use includes, but is not limited to the subcutaneous, intramuscular, interspinous, epidural, peridural, parenteral or intrathecal routes. Additonally, intranasal administration is discussed as a method to provide therapeutic benefit. The clinical conditions of consideration include, but are not limited to the following: diseases of the brain, including neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease; migraine headache; spinal radiculopathy associated with intervertebral disc herniation, post-herpetic neuralgia, reflex sympathethic dystrophy, neuropathic pain, vertebral disc disease, low back pain, amyotrophic lateral sclerosis, chronic fatigue syndrome; and neuropsychiatric diseases, including bipolar affective disorder, anorexia nervosa, nicotine withdrawal, narcotic addiction, alcohol withdrawl, post-partum depression, and schizoaffective illness.
申请公布号 US2006051381(A1) 申请公布日期 2006.03.09
申请号 US20050262528 申请日期 2005.10.28
申请人 发明人 TOBINICK EDWARD L.
分类号 A61K39/395;A61B;A61K9/00;A61K38/17;A61K38/20;C07K16/24 主分类号 A61K39/395
代理机构 代理人
主权项
地址
您可能感兴趣的专利